SCHEMBL6334758

SCHEMBL6334758

CCCCCCCC(CCC)c1c(O)cccc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
NQO1 P15559 1/20 0.39
NAAA Q02083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6327063 1.00 MEN1 (0.45) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL6336590 1.00 MEN1 (0.45) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL6328901 0.98 MEN1 (0.42) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL2370614 0.95 MEN1 (0.46) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL2469240 0.95 MEN1 (0.46) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL2464810 0.95 MEN1 (0.46) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL2468225 0.95 MEN1 (0.46) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL2465255 0.95 MEN1 (0.46) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL21137911 0.94 MEN1 (0.44) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL1668678 0.93 MEN1 (0.40) MEN1ALDH1A1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026041386-A1 ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM UNILEVER IP HOLDINGS B.V. (NL) 2026-02-26 WO claimed
EP-3675806-B1 PERSONAL CARE COMPOSITION UNILEVER GLOBAL IP LTD (GB) 2026-01-21 EP claimed
EP-4637692-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE Unilever IP Holdings B.V. (NL) 2025-10-29 EP claimed
WO-2024132395-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE UNILEVER IP HOLDINGS B.V. (NL) 2024-06-27 WO claimed
US-20200360252-A1 A PERSONAL CARE COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2020-11-19 US claimed
EP-3675806-A1 A PERSONAL CARE COMPOSITION Unilever N.V. (NL) 2020-07-08 EP claimed
WO-2019042795-A1 A PERSONAL CARE COMPOSITION UNILEVER N.V. (NL) 2019-03-07 WO claimed
CN-1293857-C Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER PLC (NL) 2007-01-10 CN claimed
CN-1642512-A Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER PLC (NL) 2005-07-20 CN claimed
US-6863897-B2 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) 2005-03-08 US claimed
WO-2003080002-A1 STABILIZATION OF RESORCINOL DERIVATIVES IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, 2003-09-25 US claimed
EP-4743057-A1 COSMETIC SKIN CARE METHODS Unilever IP Holdings B.V. (NL) 2026-05-20 EP disclosed
EP-4701614-A1 COSMETIC COMPOSITIONS FOR MAINTAINING AND RESTORING SKIN BARRIER FUNCTION Unilever IP Holdings B.V. (NL) 2026-03-04 EP disclosed
WO-2026041386-A1 ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM UNILEVER IP HOLDINGS B.V. (NL) 2026-02-26 WO disclosed
EP-3675806-B1 PERSONAL CARE COMPOSITION UNILEVER GLOBAL IP LTD (GB) 2026-01-21 EP disclosed
US-20200360252-A1 A PERSONAL CARE COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2020-11-19 US disclosed
EP-3675806-A1 A PERSONAL CARE COMPOSITION Unilever N.V. (NL) 2020-07-08 EP disclosed
WO-2019042795-A1 A PERSONAL CARE COMPOSITION UNILEVER N.V. (NL) 2019-03-07 WO disclosed
CN-1293857-C Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER PLC (NL) 2007-01-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions RCOR1, RCOR3, MCOLN2 MEN1 866/4885ALDH1A1 906/4885MAPT 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.